Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates (Q46354821)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 May 2012

Language	Label	Description	Also known as
English	Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates	scientific article published on 30 May 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

attenuated vaccine

1 reference

based on heuristic

inferred from title

Shigella flexneri

1 reference

based on heuristic

inferred from title

author name string

Ryan T Ranallo

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Suramya Fonseka

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Tara L Boren

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Lisa A Bedford

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Robert W Kaminski

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Sejal Thakkar

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Malabi M Venkatesan

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

language of work or name

0 references

publication date

30 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

30

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

34

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

5159-5171

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Shigella are versatile mucosal pathogens that circumvent the host innate immune system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Inactivated and subunit vaccines to prevent shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Live-attenuated Shigella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

PCR-mediated gene replacement in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Developing live Shigella vaccines using lambda Red recombineering

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Parameters underlying successful protection with live attenuated mutants in experimental shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Rapid and highly efficient method for scarless mutagenesis within the Salmonella enterica chromosome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Scarless and sequential gene modification in Pseudomonas using PCR product flanked by short homology regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

The stability region of the large virulence plasmid of Shigella flexneri encodes an efficient postsegregational killing system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Surprising dependence on postsegregational killing of host cells for maintenance of the large virulence plasmid of Shigella flexneri

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.05.003

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/22658966

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46354821&oldid=2107550365"